OTCMKTS:MDCL

Medicine Man Technologies Competitors

$2.39

+0.31 (+14.90 %)

(As of 04/16/2021 12:00 AM ET)

Add

Compare

Today's Range

$2.02

Now: $2.39▼

$2.54

50-Day Range

$1.90

MA: $2.26▼

$2.80

52-Week Range

$1.05

Now: $2.39▼

$4.05

Volume211,494 shs

Average Volume84,948 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Medicine Man Technologies (OTCMKTS:MDCL) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying MDCL stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to Medicine Man Technologies, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Medicine Man Technologies vs. Innovative Industrial Properties Stock

Medicine Man Technologies (OTCMKTS:MDCL) and Innovative Industrial Properties (NYSE:IIPR) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and Innovative Industrial Properties' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicine Man Technologies	N/A	N/A	N/A	N/A	N/A
Innovative Industrial Properties	$44.67 million	96.87	$23.48 million	$3.27	55.31

Innovative Industrial Properties has higher revenue and earnings than Medicine Man Technologies.

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and Innovative Industrial Properties, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicine Man Technologies	0	0	0	0	N/A
Innovative Industrial Properties	0	2	5	0	2.71

Innovative Industrial Properties has a consensus price target of $192.4286, suggesting a potential upside of 6.57%. Given Innovative Industrial Properties' higher possible upside, analysts clearly believe Innovative Industrial Properties is more favorable than Medicine Man Technologies.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Medicine Man Technologies and Innovative Industrial Properties' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medicine Man Technologies	N/A	N/A	N/A
Innovative Industrial Properties	55.71%	6.05%	4.82%

Summary

Innovative Industrial Properties beats Medicine Man Technologies on 8 of the 8 factors compared between the two stocks.

Medicine Man Technologies vs. GrowGeneration Stock

Medicine Man Technologies (OTCMKTS:MDCL) and GrowGeneration (NASDAQ:GRWG) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and GrowGeneration's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicine Man Technologies	N/A	N/A	N/A	N/A	N/A
GrowGeneration	$79 million	33.68	$1.88 million	$0.10	455.10

GrowGeneration has higher revenue and earnings than Medicine Man Technologies.

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and GrowGeneration, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicine Man Technologies	0	0	0	0	N/A
GrowGeneration	0	3	5	0	2.63

GrowGeneration has a consensus price target of $49.5714, suggesting a potential upside of 8.78%. Given GrowGeneration's higher possible upside, analysts clearly believe GrowGeneration is more favorable than Medicine Man Technologies.

Institutional & Insider Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Medicine Man Technologies and GrowGeneration's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medicine Man Technologies	N/A	N/A	N/A
GrowGeneration	2.14%	4.68%	3.53%

Summary

GrowGeneration beats Medicine Man Technologies on 8 of the 8 factors compared between the two stocks.

Medicine Man Technologies vs. 22nd Century Group Stock

Medicine Man Technologies (OTCMKTS:MDCL) and 22nd Century Group (NYSEAMERICAN:XXII) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and 22nd Century Group's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicine Man Technologies	N/A	N/A	N/A	N/A	N/A
22nd Century Group	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and 22nd Century Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicine Man Technologies	0	0	0	0	N/A
22nd Century Group	0	0	1	0	3.00

Profitability

This table compares Medicine Man Technologies and 22nd Century Group's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medicine Man Technologies	N/A	N/A	N/A
22nd Century Group	N/A	N/A	N/A

Summary

22nd Century Group beats Medicine Man Technologies on 1 of the 1 factors compared between the two stocks.

Medicine Man Technologies vs. KushCo Stock

Medicine Man Technologies (OTCMKTS:MDCL) and KushCo (OTCMKTS:KSHB) are both industrials companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Medicine Man Technologies and KushCo's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicine Man Technologies	N/A	N/A	N/A	N/A	N/A
KushCo	$113.84 million	1.65	$-77,660,000.00	($0.68)	-1.74

Medicine Man Technologies has higher earnings, but lower revenue than KushCo.

Analyst Ratings

This is a summary of current ratings for Medicine Man Technologies and KushCo, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicine Man Technologies	0	0	0	0	N/A
KushCo	0	1	3	0	2.75

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 58.90%. Given KushCo's higher possible upside, analysts clearly believe KushCo is more favorable than Medicine Man Technologies.

Profitability

This table compares Medicine Man Technologies and KushCo's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medicine Man Technologies	N/A	N/A	N/A
KushCo	-65.89%	-47.95%	-31.39%

Institutional & Insider Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

KushCo beats Medicine Man Technologies on 5 of the 8 factors compared between the two stocks.

Medicine Man Technologies vs. NSAV Stock

Medicine Man Technologies (OTCMKTS:MDCL) and NSAV (OTCMKTS:NSAV) are both industrials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Valuation & Earnings

This table compares Medicine Man Technologies and NSAV's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicine Man Technologies	N/A	N/A	N/A	N/A	N/A
NSAV	N/A	N/A	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Medicine Man Technologies and NSAV, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicine Man Technologies	0	0	0	0	N/A
NSAV	0	0	0	0	N/A

Profitability

This table compares Medicine Man Technologies and NSAV's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medicine Man Technologies	N/A	N/A	N/A
NSAV	N/A	N/A	N/A

Medicine Man Technologies vs. Terra Tech Stock

Medicine Man Technologies (OTCMKTS:MDCL) and Terra Tech (OTCMKTS:TRTC) are both industrials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Valuation & Earnings

This table compares Medicine Man Technologies and Terra Tech's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medicine Man Technologies	N/A	N/A	N/A	N/A	N/A
Terra Tech	$28.05 million	2.15	$-46,930,000.00	N/A	N/A

Medicine Man Technologies has higher earnings, but lower revenue than Terra Tech.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Medicine Man Technologies and Terra Tech, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medicine Man Technologies	0	0	0	0	N/A
Terra Tech	0	0	0	0	N/A

Profitability

This table compares Medicine Man Technologies and Terra Tech's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medicine Man Technologies	N/A	N/A	N/A
Terra Tech	-261.88%	-110.38%	-62.41%

Institutional and Insider Ownership

0.1% of Terra Tech shares are held by institutional investors. 6.7% of Terra Tech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.